Lymphoproliferative Disorders of the Orbit and Ocular Adnexa
Lymphoma is the most common malignancy to affect the orbit and is frequently a diagnostic challenge for the radiologist. Any orbital and/or ocular adnexal structure may be involved with lymphoproliferative disease, and many conditions, such as idiopathic orbital inflammation and metastatic
disease, may have a similar appearance on CT or MR imaging. Almost all ocular adnexal lymphomas are of the non-Hodgkin B-cell type. These vary in aggressiveness from the low-grade mucosa-associated lymphoid tissue type lymphoma to the highly malignant mantle-cell lymphoma, which is a disseminated
disease with a poor prognosis. In this review article, we describe the CT and MR imaging findings in the various types of ocular adnexal lymphomas, its differential diagnosis, and prognostic implications. Histopathologic and genetic characteristics are briefly covered. Treatments of some conditions
are briefly discussed.
Learning Objectives: To help the reader recognize the ubiquitous imaging findings in ocular adnexal lymphoproliferative diseases and to formulate a meaningful differential diagnosis vis-a-vis conditions with similar imaging appearances.
Learning Objectives: To help the reader recognize the ubiquitous imaging findings in ocular adnexal lymphoproliferative diseases and to formulate a meaningful differential diagnosis vis-a-vis conditions with similar imaging appearances.
Keywords: ACC = adenoid cystic carcinoma; CLL/SLL = chronic lymphocytic leukemia/small cell lymphoma; DLBCL = diffuse large B-cell lymphoma; EOM = extraocular muscle; FL = follicular lymphoma; IOID = idiopathic orbital inflammatory disease; IgG4 = immunoglobulin G4; IgG4-ROD = IgG4-related orbital disease; LH = lymphoid hyperplasia; MALT = mucosa-associated lymphoid tissue type; OA = ocular adnexa; OAL = ocular adnexal lymphoma
Document Type: Research Article
Publication date: October 1, 2020
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content